The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy

Australasian Physical and Engineering Sciences in Medicine

Volumn 38, Issue 1, 2015, Pages 55-61

  Smith, Ryan L ^a,b,c   Panettieri, Vanessa ^a   Lancaster, Craig ^d   Mason, Natasha ^a   Franich, Rick D ^b   Millar, Jeremy L ^a,b,c  

^a ALFRED HOSPITAL   (Australia)

^b Monash Partners Comprehensive Cancer Consortium   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

DTDC; Dwell time deviation constraint; HDR prostate brachytherapy; Inverse planning simulated annealing; IPSA

Indexed keywords

CATHETERS; DOSIMETRY; MODULATION; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY; SIMULATED ANNEALING; UROLOGY;

DTDC; DWELL TIME; INVERSE PLANNING; IPSA; PROSTATE BRACHYTHERAPY;

CONSTRAINED OPTIMIZATION;

ARTICLE; BRACHYTHERAPY; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; DWELL TIME DEVIATION CONSTRAINT; HIGH DOSE RATE PROSTATE BRACHYTHERAPY; HISTOGRAM; HUMAN; INVERSE PLANNING BY SIMULATED ANNEALING; MALE; MODULATION; PLANNING TARGET VOLUME; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RADIATION DOSE; RADIATION MEASUREMENT; RADIOTHERAPY PLANNING SYSTEM; URETHRA; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROSTATIC NEOPLASMS;

BRACHYTHERAPY; COHORT STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84930507179     PISSN: 01589938     EISSN: 18795447     Source Type: Journal    
DOI: 10.1007/s13246-014-0317-2     Document Type: Article

References (21)

1. Hoskin PJ, Colombo A, Henry A et al (2013) GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update. Radiother Oncol 107:325–332
2. Rivard MJ, Venselaar JL, Beaulieu L (2009) The evolution of brachytherapy treatment planning. Med Phys 36:2136–2153
3. Vicini F, Vargas C, Gustafson G et al (2003) High dose rate brachytherapy in the treatment of prostate cancer. World J Urol 21:220–228
4. Hsu IC, Lessard E, Weinberg V et al (2004) Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy. 3:147–152
5. Citrin D, Ning H, Guion P et al (2005) Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys 61:1267–1275
6. Morton GC, Sankreacha R, Halina P et al (2008) A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy. Brachytherapy. 7:12–16
7. Lessard E, Pouliot J (2001) Inverse planning anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function. Med Phys 28:773–779
8. Jacob D, Raben A, Sarkar A et al (2008) Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques. Int J Radiat Oncol Biol Phys 72:820–827
9. Kolkman-Deurloo IK, Visser AG, Niel CG et al (1994) Optimization of interstitial volume implants. Radiother Oncol 31:229–239
10. Kim Y, Hsu IC, Lessard E et al (2004) Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys 59:1208–1216
11. Hoskin PJ, Bownes PJ, Ostler P et al (2003) High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 68:285–288
12. Fox CD, Kron T, Leahy M et al (2011) Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy. Med Phys 38:5838–5843
13. Damore SJ, Syed AM, Puthawala AA et al (2000) Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 46:1205–1211
14. Tiong A, Bydder S, Ebert M et al (2010) A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible. Int J Radiat Oncol Biol Phys 76:1066–1072
15. Whitaker M, Hruby G, Lovett A et al (2011) Prostate HDR brachytherapy catheter displacement between planning and treatment delivery. Radiother Oncol 101:490–494
16. Nucletron an Elekta company EA, Stockholm, Sweden. Oncentra Brachy v4.3 Physics and Algorithms. 2013. Section 7.5.6.13, p 7–52
17. Karabis A, Giannouli S, Baltas D (2005) HIPO: a hybrid inverse treatment planning optimization algorithm in HDR brachytherapy. Radioth Oncol. 76:S29
18. Mavroidis P, Katsilieri Z, Kefala V et al (2010) Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants. J Contemp Brachytherapy. 2:117–128
19. Yamada Y, Rogers L, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 11:20–32
20. Hsu IC, Bae K, Shinohara K et al (2010) Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys 78:751–758
21. Zamboglou N, Tselis N, Baltas D et al (2013) High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results. Int J Radiat Oncol Biol Phys 85:672–678